⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL155016 | 0.83 | — | — | |
| SCHEMBL30831383 | 0.83 | — | — | |
| SCHEMBL2164254 | 0.83 | — | — | |
| Bromide SCHEMBL4614037 | 0.79 | — | — | |
| SCHEMBL5684789 | 0.79 | — | — | |
| Hydrochloric Acid SCHEMBL21591829 | 0.79 | — | — | |
| Phosphine SCHEMBL1204086 | 0.79 | — | — | |
| SCHEMBL4611417 | 0.77 | — | — | |
| Ethyne SCHEMBL15929298 | 0.75 | — | — | |
| SCHEMBL4612089 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1633762-B1 | Paracyclophanes | JOHNSON MATTHEY PLC (GB) | 2008-10-29 | — | — | EP | disclosed |
| US-7256302-B2 | Catalyst ligand with groups on one or both of the benzene rings in a paracyclophane structure; high activity and selectivity for asymmetric reactions, facilitate chiral resolution | JOHNSON MATTHEY PLC (GB) | 2007-08-14 | — | — | US | disclosed |
| US-20060229473-A1 | Catalyst ligand with groups on one or both of the benzene rings in a paracyclophane structure; high activity and selectivity for asymmetric reactions, facilitate chiral resolution | JOHNSON MATTHEY PLC (GB) | 2006-10-12 | — | — | US | disclosed |
| EP-1633762-A1 | LIGANDS | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2006-03-15 | — | — | EP | disclosed |
| WO-2004111065-A1 | LIGANDS | JOHNSON MATTHEY PLC (GB) | 2004-12-23 | — | — | WO | disclosed |